TipRanks
Advertisement
Advertisement

LBRX Stock Latest News

LB Pharmaceuticals management to meet with Piper Sandler
The FlyLB Pharmaceuticals management to meet with Piper Sandler
18h ago
LBRX
LB presents preclinical data ‘supporting’ LB-102’s mechanism of action
PremiumThe Fly
LB presents preclinical data ‘supporting’ LB-102’s mechanism of action
11d ago
LBRX
LB Pharmaceuticals initiated with a Buy at Canaccord
PremiumThe Fly
LB Pharmaceuticals initiated with a Buy at Canaccord
13d ago
LBRX
LB Pharmaceuticals initiated with a Buy at Canaccord
PremiumThe Fly
LB Pharmaceuticals initiated with a Buy at Canaccord
13d ago
LBRX
Guggenheim stats LB Pharmaceuticals at Buy, calls best idea
PremiumThe Fly
Guggenheim stats LB Pharmaceuticals at Buy, calls best idea
17d ago
LBRX
LB Pharmaceuticals initiated with a Buy at Guggenheim
PremiumThe FlyLB Pharmaceuticals initiated with a Buy at Guggenheim
17d ago
LBRX
LB Pharmaceuticals downgraded to Neutral from Buy at Roth Capital
Premium
The Fly
LB Pharmaceuticals downgraded to Neutral from Buy at Roth Capital
17d ago
LBRX
LB Pharmaceuticals initiated with a Buy at Needham
Premium
The Fly
LB Pharmaceuticals initiated with a Buy at Needham
20d ago
LBRX
Analyst Initiates Buy Rating on LB-102 for De-Risked Antipsychotic Profile, Multi-Indication Potential and Strong Long-Term Revenue Outlook
PremiumRatings
Analyst Initiates Buy Rating on LB-102 for De-Risked Antipsychotic Profile, Multi-Indication Potential and Strong Long-Term Revenue Outlook
20d ago
LBRX
LB Pharmaceuticals files automatic mixed securities shelf
PremiumThe Fly
LB Pharmaceuticals files automatic mixed securities shelf
21d ago
LBRX
LB Pharmaceuticals Appoints Susan Kozauer as Chief Medical Officer
PremiumCompany Announcements
LB Pharmaceuticals Appoints Susan Kozauer as Chief Medical Officer
1M ago
8K
LBRX
LB Pharmaceuticals Appoints Joseph Miller as New CFO
PremiumCompany Announcements
LB Pharmaceuticals Appoints Joseph Miller as New CFO
2M ago
8K
LBRX
LB Pharmaceuticals appoints Joseph Miller as CFO
PremiumThe FlyLB Pharmaceuticals appoints Joseph Miller as CFO
2M ago
AUPH
LBRX
LB Pharmaceuticals price target raised to $60 from $45 at H.C. Wainwright
Premium
The Fly
LB Pharmaceuticals price target raised to $60 from $45 at H.C. Wainwright
2M ago
LBRX
LB Pharmaceuticals price target raised to $69 from $45 at Clear Street
Premium
The Fly
LB Pharmaceuticals price target raised to $69 from $45 at Clear Street
2M ago
LBRX
LB Pharmaceuticals price target raised to $54 from $46 at BMO Capital
PremiumThe Fly
LB Pharmaceuticals price target raised to $54 from $46 at BMO Capital
2M ago
LBRX
LB Pharmaceuticals price target raised to $53 from $40 at Stifel
PremiumThe Fly
LB Pharmaceuticals price target raised to $53 from $40 at Stifel
2M ago
LBRX
LB Pharmaceuticals management to meet with Piper Sandler
PremiumThe Fly
LB Pharmaceuticals management to meet with Piper Sandler
2M ago
LBRX
LB Pharmaceuticals: Strong Balance Sheet, Clear Clinical Milestones Underpin Buy Rating; 12-Month $45 Price Target Reiterated
PremiumRatings
LB Pharmaceuticals: Strong Balance Sheet, Clear Clinical Milestones Underpin Buy Rating; 12-Month $45 Price Target Reiterated
3M ago
LBRX
LB Pharmaceuticals Announces $150 Million Private Placement Financing
PremiumCompany AnnouncementsLB Pharmaceuticals Announces $150 Million Private Placement Financing
3M ago
8K
LBRX
LB Pharmaceuticals announces $150M private placement
Premium
The Fly
LB Pharmaceuticals announces $150M private placement
3M ago
LBRX
LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained
Premium
Ratings
LB Pharmaceuticals: Buy Rating Reaffirmed on LB-102 Clinical Momentum and Regulatory Progress; $45 Price Target Maintained
3M ago
LBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >